Skip to content

Clinical trials

Completed Hemorrhage trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhage Status: Completed Country / region: Australia Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20072
20101
20111
20131
20141
20151
20161
20191
20211
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ethicon, Inc.2
AstraZeneca1
Bayside Health1
Boehringer Ingelheim1
CSL Limited1
Gold Coast Hospital and Health Service1
Idorsia Pharmaceuticals Ltd.1
Merit Medical Systems, Inc.1
NHS Blood and Transplant1
Philip Spinella1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhage14
Wounds and Injuries2
Acidosis, Lactic1
Arrhythmias, Cardiac1
Cataplexy1
Cross Infection1
Death, Sudden, Cardiac1
Disseminated Intravascular Coagulation1
Embolism1
Heart Arrest1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.